HomeMy WebLinkAboutUWSC12491 AMD 1 NEResearch Subaward Agreement
Amendment
Prime Recipient
University of Washington (UW)
Subrecipient
County of Kittitas
UW Principal Investigator (PI):
Sara Glick
Subrecipient Principal Investigator (PI):
Chelsey Loeffers
Awarding Agency: Subaward No.: Award No:
5 NU65PS923685-03-00 CDC UWSC11930
Project Title:
National Harm Reduction Technical Assistance and Syringe Services Program Monitoring and Evaluation
Subaward Period of Performance: Amount Funded This Action: Amendment No: Purchase Order No:
Start Date: 9/30/2020 End Date: 9/29/2022 $81,021 1 BPO60033
Subject to FFATA Amendment Effective Date:
9/29/2021
Total Amount of Funds Obligated to date:
$176,957 ☒Yes ☐ No
Amendment(s) to Original Terms and Conditions
This Amendment revises the above-referenced Research Subaward Agreement as follows:
Action:
The period of performance end date is changed from 09/29/2021 to 09/29/2022.
The Subaward Amount Funded this Action is increased $81,021.
The cumulative total of $95,936 should be changed to $176,957.
The amount presently available for payment is $81,021 for the budget period 09/30/2021 through 09/29/2022.
Carryforward of funds from previous period is restricted and requires prior approval.
The BPO number has changed from BPO55135 to BPO60033.
The Scope of Work is hereby amended to update the existing Scope of Work.
The Revised Scope of Work and Budget are attached and hereby appended to this amendment as Attachment 5.
All other terms and conditions of this Subaward Agreement remain in full force and effect.
By an Authorized Official of Prime Recipient: By an Authorized Official of Subrecipient:
Name: Date: Name: Date:
Title: Title:
UW Research Version JAN 2019
UWSC12491
AMD #1
ATTACHMENT 5
Research Subaward Agreement
STATEMENT OF WORK
If award is FFATA eligible and SOW exceeds 4000 characters, include a Subrecipient Federal Award Project Description
UWSC12491
AMD #1
Project NEXUS
(Injection Drug Use Surveillance Project)
Scope of Work
Subcontract: Kittitas County Public Health Department
(Never Share Syringe Exchange)
Components 2a*
1.Participate in weekly videoconference calls with University of Washington (UW) and other partners to
receive guidance and training on Project NEXUS activities.
a.Provide ongoing feedback to UW on protocol implementation issues or concerns.
2.Recruit and enroll 150 (up to 175) people who inject drugs and their drug using peers to participate in
Project NEXUS activities at the Never Share Syringe Exchange at KCPHD.
a.Appropriately staff Project NEXUS at your enrollment site.
b.Provide Project NEXUS staff and participants with COVID-19 protective materials (e.g., effective
facial coverings, and other personal protective equipment).
c.Closely adhere to Project NEXUS guidance documents for data collection, participant and staff safety
precautions.
d.Closely adhere to Project NEXUS timelines and communicate any risks to the timeline.
*All work to be completed in collaboration with the UW and other project partners.
ATTACHMENT 5
Cost Reimbursement Research Subaward Agreement
Budget
UW Research Budget Template SEP 2016
Direct Costs $63,118
☐TDC ☐MTDC ☐Other Indirect Costs $17,902Indirect Cost Rate (IDC) of 38%
De Minimis rate applied? ☒ (Check if YES) TOTAL COSTS $81,021
Salaries $47,112
Employee Benefits $8,057
Equipment $0
Travel
Supplies $900
Other Direct Costs
Total Direct Costs $63,119
Indirect Cost 38% of Salaries & Wages*$17,902
GRAND TOTAL $81,021
*Indirect costs at 38% in accordance with Subrecipient negotiated rates approved 12/31/2019.
$0
$7,050
UWSC12491
AMD #1
X